Log in to save to my catalogue

Primary breast lymphoma: a single-institute experience in Taiwan

Primary breast lymphoma: a single-institute experience in Taiwan

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_41029817666a4fc6804e48cd9222ea65

Primary breast lymphoma: a single-institute experience in Taiwan

About this item

Full title

Primary breast lymphoma: a single-institute experience in Taiwan

Publisher

United States: Elsevier Limited

Journal title

Biomedical journal, 2014-09, Vol.37 (5), p.321-325

Language

English

Formats

Publication information

Publisher

United States: Elsevier Limited

More information

Scope and Contents

Contents

Breast is an uncommon location of lymphoma involvement. The most common type of primary breast lymphoma (PBL) is diffuse large B-cell lymphoma (DLBCL). Rituximab is the widely used monoclonal antibody against CD20+ B-cell lymphoma, especially DLBCL. We aimed to analyze the clinical features, prognostic factors, and treatment outcome with or without...

Alternative Titles

Full title

Primary breast lymphoma: a single-institute experience in Taiwan

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_41029817666a4fc6804e48cd9222ea65

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_41029817666a4fc6804e48cd9222ea65

Other Identifiers

ISSN

2319-4170

E-ISSN

2320-2890

DOI

10.4103/2319-4170.132889

How to access this item